BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Brivaracetam readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Brivaracetam\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05899764-8844@assetmemo.bio
DTSTAMP:20261121T005427Z
DTSTART;VALUE=DATE:20290601
DTEND;VALUE=DATE:20290602
SUMMARY:Brivaracetam: Phase 1/2 readout est. (NCT05899764)
DESCRIPTION:Brivaracetam\, phase 1/2.\nStudy: Epileptic Hippocampus in Alzh
 eimer's Disease\nEstimated primary completion: 1 June 2029. This is a Clin
 icalTrials.gov estimate\, not a confirmed readout date\, and it can move.\
 nDrug page: https://assetmemo.bio/drug/brivaracetam#upcoming-events\nRegis
 try record: https://clinicaltrials.gov/study/NCT05899764
URL:https://assetmemo.bio/drug/brivaracetam#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06315322-8844@assetmemo.bio
DTSTAMP:20261121T005427Z
DTSTART;VALUE=DATE:20291116
DTEND;VALUE=DATE:20291117
SUMMARY:Brivaracetam: Phase 3 readout est. (NCT06315322)
DESCRIPTION:Brivaracetam\, phase 3\, Epilepsy.\nStudy: A Study to Test the 
 Long-term Safety and Tolerability of Brivaracetam in Study Participants Wi
 th Childhood Absence Epilepsy or Juvenile Absence Epilepsy\nEstimated prim
 ary completion: 16 November 2029. This is a ClinicalTrials.gov estimate\, 
 not a confirmed readout date\, and it can move.\nDrug page: https://assetm
 emo.bio/drug/brivaracetam#upcoming-events\nRegistry record: https://clinic
 altrials.gov/study/NCT06315322
URL:https://assetmemo.bio/drug/brivaracetam#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT04715646-8844@assetmemo.bio
DTSTAMP:20261121T005427Z
DTSTART;VALUE=DATE:20300708
DTEND;VALUE=DATE:20300709
SUMMARY:Brivaracetam: Phase 3 readout est. (NCT04715646)
DESCRIPTION:Brivaracetam\, phase 3\, Epilepsy.\nStudy: A Study to Test the 
 Safety and Tolerability of Brivaracetam in Children and Adolescents With S
 eizures\nEstimated primary completion: 8 July 2030. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/brivaracetam#upcoming-events\nRegistry reco
 rd: https://clinicaltrials.gov/study/NCT04715646
URL:https://assetmemo.bio/drug/brivaracetam#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
